1996
DOI: 10.1128/aac.40.4.1009
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals

Abstract: The quinolone resistance-determining regions (QRDRs) of the gyrA genes of quinolone-resistant clinical and veterinary salmonella isolates were sequenced. Substitutions analogous to a substitution of a Ser to a Phe at position 83 (Ser83-->Phe) and Asp87-->Gly or Tyr in Escherichia coli were found, as was a single novel mutation outside of the QRDR resulting in Ala119-->Glu. The data suggest that gyrA mutations are associated with quinolone resistance in veterinary and clinical salmonella isolates and t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
84
1

Year Published

1997
1997
2012
2012

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 159 publications
(89 citation statements)
references
References 29 publications
2
84
1
Order By: Relevance
“…Changes in GyrB are rarely found in Salmonella but Tyr420 → Cys and Arg437 → Leu may be found. Changes in ParE have been observed most rarely and may be Glu453 → Gly, His461 → Tyr, Ala498 → Thr, Val512 → Gly and Ser518 → Cys [37][38][39][40][41][42].…”
Section: Mechanisms Of Resistance To Quinolones In Salmonella Sppmentioning
confidence: 96%
“…Changes in GyrB are rarely found in Salmonella but Tyr420 → Cys and Arg437 → Leu may be found. Changes in ParE have been observed most rarely and may be Glu453 → Gly, His461 → Tyr, Ala498 → Thr, Val512 → Gly and Ser518 → Cys [37][38][39][40][41][42].…”
Section: Mechanisms Of Resistance To Quinolones In Salmonella Sppmentioning
confidence: 96%
“…Bacterial resistance to quinolones or fluoroquinolones is usually accomplished by interference with bacterial DNA metabolism mediated by mutations in bacterial DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE) genes, as well as by active efflux (Eaves et al, 2004;Griggs, Gensberg, & Piddock, 1996;Piddock, 2002;Piddock, Ricci, McLaren, & Griggs, 1998). These mutations prevent antimicrobial agents from binding to their topoisomerase targets and carrying out their antimicrobial activity (Heisig, 1993).…”
Section: Antimicrobial Resistance Mechanismsmentioning
confidence: 99%
“…PCR amplification of the segment of the gyrA gene encoding the QRDR region of GyrA was performed using previously described specific primers [10]. Owing to the absence of CIP-resistant (CIP R ) isolates, only substitutions in QRDR of GyrA were considered as the most relevant [1].…”
Section: Pcr Amplification Of the Qrdr-encoding Segment Of The Gyra Genementioning
confidence: 99%